Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

European Commission Grants Marketing Authorisation for MSD’s ZEPATIER™ (elbasvir/grazoprevir) for the Treatment of Chronic Hepatitis C Infection

Editor's pick
MSD press release
2 August 2016
Hepatitis C treatment

Addaction publishes major new poll on World Hepatitis Day: 4 in 5 British adults say NHS wrong to restrict access to treatment

Editor's pick
Addaction
28 July 2016
Hepatitis C treatment

Hepatitis C will be eradicated from Australia in a decade, doctors say

Editor's pick
Sydney Morning Herald
28 July 2016
Hepatitis C treatment

NHS England tried to sabotage hepatitis C drugs release because it couldn't afford them, doctors claim

Editor's pick
The Independent
28 July 2016
Hepatitis C treatment

CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX® for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)

Editor's pick
AbbVie press release
26 July 2016
Hepatitis C treatment

Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study

News
21 July 2016
Access to healthcare

WHO Updates Patent Status Info For New Hepatitis C Medicines

Editor's pick
Intellectual Property Watch
21 July 2016
Hepatitis C treatment

'World has ignored hepatitis at its peril,' warns UN health agency ahead of World Day

Editor's pick
UN News Centre
21 July 2016
Hepatitis C treatment

Fast Advance in Hepatitis C Care Prompts EMA to Revise Clinical Trial Guideline

Editor's pick
Regulatory Affairs Professionals Society
17 July 2016
Hepatitis C treatment

'It's Destroyed People's Lives': The Shocking Rise in Hepatitis C-Related Deaths

Editor's pick
VICE
22 June 2016
Pharmaceutical industry

What Do Gilead And Martin Shkreli Have In Common?

Editor's pick
Seeking Alpha
22 June 2016
Hepatitis C treatment

Hepatitis C: Treating People Who Inject Drugs

Editor's pick
HCV Next
21 June 2016
Hepatitis C treatment

Fighting the War on HCV Within the Veterans Health Administration System

Editor's pick
HCV Next
21 June 2016
Hepatitis C treatment

Punjab: Government launches special fund for free treatment of Hepatitis C

Editor's pick
Indian Express
20 June 2016
Hepatitis C treatment

Sofosbuvir/ledipasvir regimens can cost less per cure than older hepatitis C treatments

News
15 June 2016
Hepatitis C treatment

Hep C sufferers’ ire at activist-website ban

Editor's pick
The New Daily
15 June 2016
Hepatitis C treatment

Ireland to expand hepatitis C treatment programme

Editor's pick
Irish Times
15 June 2016
Hepatitis C treatment

A boring killer?

Editor's pick
Addaction
14 June 2016
Hepatitis C treatment

Race does not impact early mortality among patients with chronic HCV

Editor's pick
Healio
13 June 2016
Hepatitis C treatment

New HCV therapies unaffordable to health systems and individuals

News
9 June 2016
Hepatitis C treatment

People from occupied territories receive Georgian citizenship for free Hepatitis C treatment

Editor's pick
Agenda.ge
7 June 2016
Hepatitis C treatment

Ele Hamburger: Medicaid programs should be taking “a long hard look” at their drug policies under state and federal law

Editor's pick
State of Reform
7 June 2016
Hepatitis C treatment

Australia shows an alternative to rationing hepatitis C treatment

News
6 June 2016
Hepatitis C treatment

How to meet the first-ever global hepatitis targets

Editor's pick
International AIDS Society
6 June 2016